ArticlePaediatric drugs2013
Pharmacologically assisted treatment of opioid-dependent youth.
Article in Paediatric drugs, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 21 citations in OpenAlex.
- Extended-release naltrexone for youth with opioid use disorder.Journal of substance abuse treatment · 2021Trial
- Patient and provider medication preferences affect treatment outcomes among adolescents and young adults with opioid use disorder.Journal of substance use and addiction treatment · 2024Article
- Buprenorphine and its formulations: a comprehensive review.Health psychology research · 2022Article
- Comorbid chronic pain and opioid misuse in youth: Knowns, unknowns, and implications for behavioral treatment.The American psychologist · 2020Review
- Age related medication for addiction treatment (MAT) use for opioid use disorder among Medicaid-insured patients in New York.Substance abuse treatment, prevention, and policy · 2019Article
- Medication-assisted treatment for youth with opioid use disorder: Current dilemmas and remaining questions.The American journal of drug and alcohol abuse · 2018Article
- Still "at risk": An examination of how street-involved young people understand, experience, and engage with "harm reduction" in Vancouver's inner city.The International journal on drug policy · 2017Article
- Non-medical prescription opioid use predicts injection initiation among street-involved youth.The International journal on drug policy · 2016Article
- Inability to access addiction treatment predicts injection initiation among street-involved youth in a Canadian setting.Substance abuse treatment, prevention, and policy · 2016Article
- Buprenorphine Treatment for Adolescents and Young Adults With Opioid Use Disorders: A Narrative Review.Journal of addiction medicineReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
Abstract
Opioid misuse, abuse, and dependence are global problems whose patterns vary across cultures. In the USA, the non-medical use of prescription opioids has become particularly serious because of its association with addiction and overdose death. Agonist and antagonist medications have been shown to be effective for opioid-dependent adults, and there is a growing body of data that they are also effective for youth. Here, we summarize evidence that detoxification alone results in high rates of treatment dropout and relapse but that the limited but growing data on the extended use of medication-assisted treatment for opioid-dependent youth have been positive. The implementation of medication-assisted treatment as a standard practice is feasible, easily integrated with counseling or psychotherapy, and has potential to greatly improve outcomes. Although concerns about safety and efficacy with youth require more research, and we do not advocate indefinite maintenance, we suggest that opioid-dependent youth should be considered as candidates for medication-assisted treatment delivered in a comprehensive, developmentally appropriate context, beginning at the first episode of care, with the strength of the recommendation to use medication increasing with each care episode.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.